{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:07:26Z","timestamp":1786993646123,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["R01 AI081757"],"award-info":[{"award-number":["R01 AI081757"]}]},{"name":"NIH","award":["U19 A1063603"],"award-info":[{"award-number":["U19 A1063603"]}]},{"name":"NIH","award":["U01 GM094653"],"award-info":[{"award-number":["U01 GM094653"]}]},{"name":"NIH","award":["U01 AI084146"],"award-info":[{"award-number":["U01 AI084146"]}]},{"name":"NIH","award":["TL1 RR025772"],"award-info":[{"award-number":["TL1 RR025772"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lrjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.leukres.2018.09.009","type":"journal-article","created":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T12:12:34Z","timestamp":1537618354000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Expression of the miR-150 tumor suppressor is restored by and synergizes with rapamycin in a human leukemia T-cell line"],"prefix":"10.1016","volume":"74","author":[{"given":"Katie","family":"Podshivalova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen A.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1880-3341","authenticated-orcid":false,"given":"Traver","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Salomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2018.09.009_bib0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrm3025","article-title":"mTOR: from growth signal integration to cancer, diabetes and ageing","volume":"12","author":"Zoncu","year":"2011","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.leukres.2018.09.009_bib0010","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1182\/blood-2009-06-229443","article-title":"Constitutively active AKT depletes hematopoietic stem cells and induces leukemia in mice","volume":"115","author":"Kharas","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2018.09.009_bib0015","doi-asserted-by":"crossref","first-page":"156","DOI":"10.18632\/oncotarget.119","article-title":"Role of Pten in leukemia stem cells","volume":"1","author":"Peng","year":"2010","journal-title":"Oncotarget"},{"key":"10.1016\/j.leukres.2018.09.009_bib0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/leu.2009.223","article-title":"Targeted therapy in T-cell malignancies: dysregulation of the cellular signaling pathways","volume":"24","author":"Zhao","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2018.09.009_bib0025","doi-asserted-by":"crossref","first-page":"e102494","DOI":"10.1371\/journal.pone.0102494","article-title":"mTOR inhibition by everolimus in childhood acute lymphoblastic leukemia induces caspase-independent cell death","volume":"9","author":"Baraz","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.leukres.2018.09.009_bib0030","doi-asserted-by":"crossref","first-page":"811","DOI":"10.18632\/oncotarget.579","article-title":"Harnessing the PI3K\/Akt\/mTOR pathway in T-cell acute lymphoblastic leukemia: eliminating activity by targeting at different levels","volume":"3","author":"Bressanin","year":"2012","journal-title":"Oncotarget"},{"key":"10.1016\/j.leukres.2018.09.009_bib0035","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1182\/blood-2008-02-137752","article-title":"Potentiating effects of RAD001 (Everolimus) on vincristine therapy in childhood acute lymphoblastic leukemia","volume":"113","author":"Crazzolara","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2018.09.009_bib0040","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/leu.2010.226","article-title":"A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma","volume":"25","author":"Witzig","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2018.09.009_bib0045","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1158\/1078-0432.CCR-14-2888","article-title":"A phase I\/II study of the mTOR inhibitor everolimus in combination with HyperCVAD chemotherapy in patients with Relapsed\/Refractory acute lymphoblastic leukemia","volume":"21","author":"Daver","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.leukres.2018.09.009_bib0050","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2018.09.009_bib0055","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.molonc.2012.09.006","article-title":"MicroRNA and cancer","volume":"6","author":"Jansson","year":"2012","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.leukres.2018.09.009_bib0060","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.molmed.2014.06.005","article-title":"MicroRNAs in cancer: biomarkers, functions and therapy","volume":"20","author":"Hayes","year":"2014","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.leukres.2018.09.009_bib0065","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1158\/0008-5472.CAN-06-2698","article-title":"Characterization of microRNA expression levels and their biological correlates in human cancer cell lines","volume":"67","author":"Gaur","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.leukres.2018.09.009_bib0070","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","article-title":"MicroRNA expression profiles classify human cancers","volume":"435","author":"Lu","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2018.09.009_bib0075","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/bioinformatics\/btt014","article-title":"miRCancer: a microRNA-cancer association database constructed by text mining on literature","volume":"29","author":"Xie","year":"2013","journal-title":"Bioinformatics"},{"issue":"Feb (4)","key":"10.1016\/j.leukres.2018.09.009_bib0080","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.molcel.2014.12.034","article-title":"An mTORC1-Mdm2-Drosha Axis for miRNA biogenesis in response to glucose- and amino acid-deprivation","volume":"57","author":"Ye","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.leukres.2018.09.009_bib0085","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1084\/jem.20111386","article-title":"miR-150 regulates the development of NK and iNKT cells","volume":"208","author":"Bezman","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.leukres.2018.09.009_bib0090","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cell.2007.07.021","article-title":"MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb","volume":"131","author":"Xiao","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2018.09.009_bib0095","doi-asserted-by":"crossref","first-page":"7080","DOI":"10.1073\/pnas.0702409104","article-title":"miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely","volume":"104","author":"Zhou","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.leukres.2018.09.009_bib0100","doi-asserted-by":"crossref","first-page":"e2371","DOI":"10.1038\/cddis.2016.256","article-title":"miR-150 exerts antileukemia activity in vitro and in vivo through regulating genes in multiple pathways","volume":"7","author":"Fang","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.leukres.2018.09.009_bib0105","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/leu.2011.81","article-title":"The role of microRNA-150 as a tumor suppressor in malignant lymphoma","volume":"25","author":"Watanabe","year":"2011","journal-title":"Leukemia"},{"issue":"Mar. (10)","key":"10.1016\/j.leukres.2018.09.009_bib0110","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1182\/blood-2013-09-527739","article-title":"MicroRNA-150 inhibits tumor invasion and metastasis by targeting the chemokine receptor CCR6 in advanced cutaneous T-cell lymphoma","volume":"123","author":"Ito","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2018.09.009_bib0115","doi-asserted-by":"crossref","first-page":"7053","DOI":"10.1182\/blood-2010-12-326629","article-title":"Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150","volume":"117","author":"Ghisi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2018.09.009_bib0120","doi-asserted-by":"crossref","first-page":"D152","DOI":"10.1093\/nar\/gkq1027","article-title":"miRBase: integrating microRNA annotation and deep-sequencing data","volume":"39","author":"Kozomara","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.leukres.2018.09.009_bib0125","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/gb-2009-10-3-r25","article-title":"Ultrafast and memory-efficient alignment of short DNA sequences to the human genome","volume":"10","author":"Langmead","year":"2009","journal-title":"Genome Biol."},{"key":"10.1016\/j.leukres.2018.09.009_bib0130","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1084\/jem.20111717","article-title":"T cell activation induces proteasomal degradation of Argonaute and rapid remodeling of the microRNA repertoire","volume":"210","author":"Bronevetsky","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.leukres.2018.09.009_bib0135","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2105-10-48","article-title":"GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists","volume":"10","author":"Eden","year":"2009","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.leukres.2018.09.009_bib0140","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.immuni.2010.09.002","article-title":"The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism","volume":"33","author":"Powell","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.leukres.2018.09.009_bib0145","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1172\/JCI34616","article-title":"PTEN posttranslational inactivation and hyperactivation of the PI3K\/Akt pathway sustain primary T cell leukemia viability","volume":"118","author":"Silva","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.leukres.2018.09.009_bib0150","doi-asserted-by":"crossref","first-page":"6945","DOI":"10.1128\/MCB.20.18.6945-6957.2000","article-title":"Deficiency of PTEN in Jurkat T cells causes constitutive localization of Itk to the plasma membrane and hyperresponsiveness to CD3 stimulation","volume":"20","author":"Shan","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.leukres.2018.09.009_bib0155","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/10409238.2012.738643","article-title":"MicroRNA biogenesis: regulating the regulators","volume":"48","author":"Finnegan","year":"2013","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.leukres.2018.09.009_bib0160","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","article-title":"Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB","volume":"22","author":"Sarbassov","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.leukres.2018.09.009_bib0165","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1128\/MCB.24.1.200-216.2004","article-title":"mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1\/eukaryotic translation initiation factor 4E","volume":"24","author":"Fingar","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.leukres.2018.09.009_bib0170","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/mutage\/geu045","article-title":"The expanding role of mTOR in cancer cell growth and proliferation","volume":"30","author":"Cargnello","year":"2015","journal-title":"Mutagenesis"},{"key":"10.1016\/j.leukres.2018.09.009_bib0175","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nature09267","article-title":"Mammalian microRNAs predominantly act to decrease target mRNA levels","volume":"466","author":"Guo","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2018.09.009_bib0180","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1128\/MCB.02005-06","article-title":"Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression","volume":"27","author":"Linsley","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.leukres.2018.09.009_bib0185","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.molcel.2010.03.007","article-title":"Genome-wide dissection of microRNA functions and cotargeting networks using gene set signatures","volume":"38","author":"Tsang","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.leukres.2018.09.009_bib0190","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0140-6736(08)60457-2","article-title":"Acute lymphoblastic leukaemia","volume":"371","author":"Pui","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.leukres.2018.09.009_bib0195","doi-asserted-by":"crossref","first-page":"7942","DOI":"10.1200\/JCO.2005.01.1031","article-title":"Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Munster Group 87","volume":"23","author":"Einsiedel","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2018.09.009_bib0200","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1182\/blood-2006-05-018192","article-title":"Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12\/ECOG 2993 study","volume":"109","author":"Fielding","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2018.09.009_bib0205","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.cell.2012.04.005","article-title":"Roles for microRNAs in conferring robustness to biological processes","volume":"149","author":"Ebert","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2018.09.009_bib0210","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1615\/CritRevImmunol.2013006858","article-title":"MicroRNA regulation of T-lymphocyte immunity: modulation of molecular networks responsible for T-cell activation, differentiation, and development","volume":"33","author":"Podshivalova","year":"2013","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.leukres.2018.09.009_bib0215","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1016\/j.yexcr.2006.03.029","article-title":"AU-rich elements and alternative splicing in the beta-catenin 3\u2019UTR can influence the human beta-catenin mRNA stability","volume":"312","author":"Thiele","year":"2006","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.leukres.2018.09.009_bib0220","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1126\/science.1155390","article-title":"Proliferating cells express mRNAs with shortened 3\u2019 untranslated regions and fewer microRNA target sites","volume":"320","author":"Sandberg","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.leukres.2018.09.009_bib0225","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.cell.2007.11.034","article-title":"RNA-binding protein Dnd1 inhibits microRNA access to target mRNA","volume":"131","author":"Kedde","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2018.09.009_bib0230","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.cell.2008.12.023","article-title":"Importin 8 is a gene silencing factor that targets argonaute proteins to distinct mRNAs","volume":"136","author":"Weinmann","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2018.09.009_bib0235","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.cell.2006.04.031","article-title":"Relief of microRNA-mediated translational repression in human cells subjected to stress","volume":"125","author":"Bhattacharyya","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2018.09.009_bib0240","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.molcel.2014.02.013","article-title":"Global analyses of the effect of different cellular contexts on microRNA targeting","volume":"53","author":"Nam","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.leukres.2018.09.009_bib0245","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/gt.2011.50","article-title":"MicroRNA therapeutics","volume":"18","author":"Broderick","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.leukres.2018.09.009_bib0250","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1161\/CIRCRESAHA.111.247916","article-title":"Developing microRNA therapeutics","volume":"110","author":"van Rooij","year":"2012","journal-title":"Circ. Res."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212618302157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212618302157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T13:20:20Z","timestamp":1571923220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212618302157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":50,"alternative-id":["S0145212618302157"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2018.09.009","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of the miR-150 tumor suppressor is restored by and synergizes with rapamycin in a human leukemia T-cell line","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2018.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}